218 related articles for article (PubMed ID: 11668501)
1. Comparative analysis of the NF2, TP53, PTEN, KRAS, NRAS and HRAS genes in sporadic and radiation-induced human meningiomas.
Joachim T; Ram Z; Rappaport ZH; Simon M; Schramm J; Wiestler OD; von Deimling A
Int J Cancer; 2001 Oct; 94(2):218-21. PubMed ID: 11668501
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas.
Agnihotri S; Suppiah S; Tonge PD; Jalali S; Danesh A; Bruce JP; Mamatjan Y; Klironomos G; Gonen L; Au K; Mansouri S; Karimi S; Sahm F; von Deimling A; Taylor MD; Laperriere NJ; Pugh TJ; Aldape KD; Zadeh G
Nat Commun; 2017 Aug; 8(1):186. PubMed ID: 28775249
[TBL] [Abstract][Full Text] [Related]
3. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
[TBL] [Abstract][Full Text] [Related]
4. Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas.
Papi L; De Vitis LR; Vitelli F; Ammannati F; Mennonna P; Montali E; Bigozzi U
Hum Genet; 1995 Mar; 95(3):347-51. PubMed ID: 7868131
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the PTEN gene in human meningiomas.
Peters N; Wellenreuther R; Rollbrocker B; Hayashi Y; Meyer-Puttlitz B; Duerr EM; Lenartz D; Marsh DJ; Schramm J; Wiestler OD; Parsons R; Eng C; von Deimling A
Neuropathol Appl Neurobiol; 1998 Feb; 24(1):3-8. PubMed ID: 9549723
[TBL] [Abstract][Full Text] [Related]
6. NF2 mutations in secretory and other rare variants of meningiomas.
Hartmann C; Sieberns J; Gehlhaar C; Simon M; Paulus W; von Deimling A
Brain Pathol; 2006 Jan; 16(1):15-9. PubMed ID: 16612978
[TBL] [Abstract][Full Text] [Related]
7. Radiation-induced meningioma: a distinct molecular genetic pattern?
Shoshan Y; Chernova O; Juen SS; Somerville RP; Israel Z; Barnett GH; Cowell JK
J Neuropathol Exp Neurol; 2000 Jul; 59(7):614-20. PubMed ID: 10901233
[TBL] [Abstract][Full Text] [Related]
8. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma.
Harada T; Irving RM; Xuereb JH; Barton DE; Hardy DG; Moffat DA; Maher ER
J Neurosurg; 1996 May; 84(5):847-51. PubMed ID: 8622160
[TBL] [Abstract][Full Text] [Related]
10. Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.
Zhang X; Jia H; Lu Y; Dong C; Hou J; Wang Z; Wang F; Zhong H; Wang L; Wang K
Discov Med; 2014 Dec; 18(101):301-311. PubMed ID: 25549701
[TBL] [Abstract][Full Text] [Related]
11. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.
Lekanne Deprez RH; Bianchi AB; Groen NA; Seizinger BR; Hagemeijer A; van Drunen E; Bootsma D; Koper JW; Avezaat CJ; Kley N
Am J Hum Genet; 1994 Jun; 54(6):1022-9. PubMed ID: 7911002
[TBL] [Abstract][Full Text] [Related]
12. Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas.
De Vitis LR; Tedde A; Vitelli F; Ammannati F; Mennonna P; Bigozzi U; Montali E; Papi L
Hum Genet; 1996 May; 97(5):632-7. PubMed ID: 8655144
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.
Hansson CM; Buckley PG; Grigelioniene G; Piotrowski A; Hellström AR; Mantripragada K; Jarbo C; Mathiesen T; Dumanski JP
BMC Genomics; 2007 Jan; 8():16. PubMed ID: 17222329
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of the NF2 gene in sporadic meningiomas by denaturing high-performance liquid chromatography.
Kim JH; Kim IS; Kwon SY; Jang BC; Suh SI; Shin DH; Jeon CH; Son EI; Kim SP
Int J Mol Med; 2006 Jul; 18(1):27-32. PubMed ID: 16786152
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas.
Ruttledge MH; Sarrazin J; Rangaratnam S; Phelan CM; Twist E; Merel P; Delattre O; Thomas G; Nordenskjöld M; Collins VP
Nat Genet; 1994 Feb; 6(2):180-4. PubMed ID: 8162072
[TBL] [Abstract][Full Text] [Related]
16. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
[TBL] [Abstract][Full Text] [Related]
17. Allelic losses in neurofibromatosis 2-associated meningiomas.
Lamszus K; Vahldiek F; Mautner VF; Schichor C; Tonn J; Stavrou D; Fillbrandt R; Westphal M; Kluwe L
J Neuropathol Exp Neurol; 2000 Jun; 59(6):504-12. PubMed ID: 10850863
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma.
Wellenreuther R; Kraus JA; Lenartz D; Menon AG; Schramm J; Louis DN; Ramesh V; Gusella JF; Wiestler OD; von Deimling A
Am J Pathol; 1995 Apr; 146(4):827-32. PubMed ID: 7717450
[TBL] [Abstract][Full Text] [Related]
19. Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas.
Lomas J; Bello MJ; Arjona D; Alonso ME; Martinez-Glez V; Lopez-Marin I; Amiñoso C; de Campos JM; Isla A; Vaquero J; Rey JA
Genes Chromosomes Cancer; 2005 Mar; 42(3):314-9. PubMed ID: 15609345
[TBL] [Abstract][Full Text] [Related]
20. Mutational patterns and regulatory networks in epigenetic subgroups of meningioma.
Paramasivam N; Hübschmann D; Toprak UH; Ishaque N; Neidert M; Schrimpf D; Stichel D; Reuss D; Sievers P; Reinhardt A; Wefers AK; Jones DTW; Gu Z; Werner J; Uhrig S; Wirsching HG; Schick M; Bewerunge-Hudler M; Beck K; Brehmer S; Urbschat S; Seiz-Rosenhagen M; Hänggi D; Herold-Mende C; Ketter R; Eils R; Ram Z; Pfister SM; Wick W; Weller M; Grossmann R; von Deimling A; Schlesner M; Sahm F
Acta Neuropathol; 2019 Aug; 138(2):295-308. PubMed ID: 31069492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]